The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses

Keyphrases

• Antiviral Activity 100%
• COVID-19 100%
• Mannose 100%
• 2-Deoxy-d-glucose (2-DG) 100%
• Highly Pathogenic Virus 100%
• D-glucose 100%
• Metabolic Changes 75%
• Viral Infection 50%
• Antiviral Agents 25%
• Host Cell 25%
• Intracellular Signaling 25%
• Infected Cells 25%
• Coronavirus 25%
• Pharmacokinetic Properties 25%
• Therapeutic Approaches 25%
• Influenza Virus 25%
• Glycolytic Metabolism 25%
• Antiviral Drugs 25%
• Clinical Application 25%
• Glycolysis 25%
• Zika Virus 25%
• Glucose Utilization 25%
• Common Mechanisms 25%
• Rhinovirus 25%
• Cytomegalovirus 25%
• Norovirus 25%
• Cell Adaptation 25%
• Novel Analogues 25%
• Glycolysis Inhibitors 25%

Medicine and Dentistry

• Antivirus Agent 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Mannose 100%
• Infection 66%
• Virus Infection 66%
• Host Cell 33%
• Pharmacokinetics 33%
• Coronavirus 33%
• Glucose Utilization 33%
• Cytomegalovirus 33%
• Influenza Virus 33%
• Rhinovirus 33%
• Zika Virus 33%
• Norovirus 33%
• Cell Adaptation 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antivirus Agent 100%
• SARS Coronavirus 100%
• Mannose 100%
• Infection 66%
• Virus Infection 66%
• Pharmacokinetics 33%
• Influenza Virus 33%
• Zika Virus 33%
• Cytomegalovirus 33%
• Rhinovirus 33%
• Norovirus 33%